Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lentinula edodes mycelia, commonly known as shiitake mushroom mycelium, has been explored for its potential role in supporting convalescence—the period of recovery after illness. Scientific studies have shown that L. edodes mycelia contain bioactive compounds, such as β-glucans, polysaccharides (notably lentinan), and other immunomodulatory substances. These compounds have demonstrated immune-enhancing effects in both animal and human studies. For example, lentinan has been reported to boost host immunity by activating macrophages and T-cells, and it has been used as an adjunct therapy in cancer and chronic infections in some countries, particularly in East Asia.

Human clinical trials, while mostly focused on the mushroom fruiting body, suggest that L. edodes extracts can improve immune function, increase white blood cell counts, and reduce inflammation—outcomes that may be beneficial in the convalescent phase. There are also reports that mycelial extracts can improve energy, appetite, and general well-being in recovering patients. However, the direct evidence specifically targeting "convalescence" as an outcome is limited, and much of the research extrapolates from broader immune and vitality studies. Nonetheless, the underlying scientific rationale and supporting data for immune support justify its use in this context, meriting a moderate evidence rating.

In summary, while more targeted clinical trials are needed, the immunomodulatory and restorative properties of L. edodes mycelia provide a scientific basis for its use during convalescence.

More about Lentinula edodes mycelia
More about Convalescence

Other ingredients used for Convalescence

Other health conditions supported by Lentinula edodes mycelia

Products containing Lentinula edodes mycelia

Douglas Laboratories A.H.C.C. ® Plus